181 related articles for article (PubMed ID: 37823707)
1. Guillain-Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the 'Italian factor'.
Censi S; Bisaccia G; Gallina S; Tomassini V; Uncini A
Eur J Neurol; 2024 Feb; 31(2):e16094. PubMed ID: 37823707
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.
Luijten LWG; Leonhard SE; van der Eijk AA; Doets AY; Appeltshauser L; Arends S; Attarian S; Benedetti L; Briani C; Casasnovas C; Castellani F; Dardiotis E; Echaniz-Laguna A; Garssen MPJ; Harbo T; Huizinga R; Humm AM; Jellema K; van der Kooi AJ; Kuitwaard K; Kuntzer T; Kusunoki S; Lascano AM; Martinez-Hernandez E; Rinaldi S; Samijn JPA; Scheidegger O; Tsouni P; Vicino A; Visser LH; Walgaard C; Wang Y; Wirtz PW; Ripellino P; Jacobs BC;
Brain; 2021 Dec; 144(11):3392-3404. PubMed ID: 34553216
[TBL] [Abstract][Full Text] [Related]
3. Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study.
Filosto M; Cotti Piccinelli S; Gazzina S; Foresti C; Frigeni B; Servalli MC; Sessa M; Cosentino G; Marchioni E; Ravaglia S; Briani C; Castellani F; Zara G; Bianchi F; Del Carro U; Fazio R; Filippi M; Magni E; Natalini G; Palmerini F; Perotti AM; Bellomo A; Osio M; Nascimbene C; Carpo M; Rasera A; Squintani G; Doneddu PE; Bertasi V; Cotelli MS; Bertolasi L; Fabrizi GM; Ferrari S; Ranieri F; Caprioli F; Grappa E; Manganotti P; Bellavita G; Furlanis G; De Maria G; Leggio U; Poli L; Rasulo F; Latronico N; Nobile-Orazio E; Beghi E; Padovani A; Uncini A
Eur J Neurol; 2022 Nov; 29(11):3358-3367. PubMed ID: 35837806
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis.
Hasan I; Saif-Ur-Rahman KM; Hayat S; Papri N; Jahan I; Azam R; Ara G; Islam Z
J Peripher Nerv Syst; 2020 Dec; 25(4):335-343. PubMed ID: 33112450
[TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases.
Cea G; Romero C; Aguilar S; Salinas R
Rev Med Chil; 2021 Dec; 149(12):1812-1816. PubMed ID: 35735350
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
Uncini A; Vallat JM; Jacobs BC
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
[TBL] [Abstract][Full Text] [Related]
7. COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy).
Martinelli-Boneschi F; Colombo A; Bresolin N; Sessa M; Bassi P; Grampa G; Magni E; Versino M; Ferrarese C; Zarcone D; Albanese A; Micieli G; Zanferrari C; Cagnana A; Ferrante C; Zilioli A; Locatelli D; Calloni MV; Delodovici ML; Pozzato M; Patisso V; Bortolan F; Foresti C; Frigeni B; Canella S; Xhani R; Crabbio M; Clemenzi A; Mauri M; Beretta S; La Spina I; Bernasconi S; De Santis T; Cavallini A; Ranieri M; D'Adda E; Fruguglietti ME; Peverelli L; Agosti E; Leoni O; Rigamonti A; Salmaggi A
Neurol Sci; 2023 Feb; 44(2):437-446. PubMed ID: 36289117
[TBL] [Abstract][Full Text] [Related]
8. Concomitant Guillain-Barré Syndrome and COVID-19: A Meta-Analysis of Cases.
Bentley SA; Ahmad S; Kobeissy FH; Toklu HZ
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557036
[No Abstract] [Full Text] [Related]
9. COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism.
Malekpour M; Khanmohammadi S; Meybodi MJE; Shekouh D; Rahmanian MR; Kardeh S; Azarpira N
Immun Inflamm Dis; 2023 May; 11(5):e875. PubMed ID: 37249286
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
Keddie S; Pakpoor J; Mousele C; Pipis M; Machado PM; Foster M; Record CJ; Keh RYS; Fehmi J; Paterson RW; Bharambe V; Clayton LM; Allen C; Price O; Wall J; Kiss-Csenki A; Rathnasabapathi DP; Geraldes R; Yermakova T; King-Robson J; Zosmer M; Rajakulendran S; Sumaria S; Farmer SF; Nortley R; Marshall CR; Newman EJ; Nirmalananthan N; Kumar G; Pinto AA; Holt J; Lavin TM; Brennan KM; Zandi MS; Jayaseelan DL; Pritchard J; Hadden RDM; Manji H; Willison HJ; Rinaldi S; Carr AS; Lunn MP
Brain; 2021 Mar; 144(2):682-693. PubMed ID: 33313649
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up.
Ahmad L; Businaro P; Regalbuto S; Gastaldi M; Zardini E; Panzeri M; Vegezzi E; Fiamingo G; Colombo E; Ravaglia S
Medicine (Baltimore); 2022 Jul; 101(30):e29704. PubMed ID: 35905215
[TBL] [Abstract][Full Text] [Related]
12. Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study.
Bishara H; Arbel A; Barnett-Griness O; Bloch S; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W
Neurology; 2023 Nov; 101(20):e2035-e2042. PubMed ID: 37852786
[TBL] [Abstract][Full Text] [Related]
13. Guillain-Barré syndrome associated with SARS-CoV-2 infection. A systematic review.
De Sanctis P; Doneddu PE; Viganò L; Selmi C; Nobile-Orazio E
Eur J Neurol; 2020 Nov; 27(11):2361-2370. PubMed ID: 32757404
[TBL] [Abstract][Full Text] [Related]
14. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
Caress JB; Castoro RJ; Simmons Z; Scelsa SN; Lewis RA; Ahlawat A; Narayanaswami P
Muscle Nerve; 2020 Oct; 62(4):485-491. PubMed ID: 32678460
[TBL] [Abstract][Full Text] [Related]
15. COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy.
Garnero M; Del Sette M; Assini A; Beronio A; Capello E; Cabona C; Reni L; Serrati C; Bandini F; Granata A; Pesce G; Mancardi GL; Uccelli A; Schenone A; Benedetti L
J Neurol Sci; 2020 Nov; 418():117114. PubMed ID: 32947089
[TBL] [Abstract][Full Text] [Related]
16. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?
Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X
Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799
[TBL] [Abstract][Full Text] [Related]
17. Two case reports and a literature review of typical GBS and rare GBS variants associated with COVID-19.
Orak SA; Kubur ÇÇ; Atasever AK; Polat M
Arch Pediatr; 2023 May; 30(4):236-239. PubMed ID: 37069023
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
Abu-Rumeileh S; Abdelhak A; Foschi M; Tumani H; Otto M
J Neurol; 2021 Apr; 268(4):1133-1170. PubMed ID: 32840686
[TBL] [Abstract][Full Text] [Related]
19. Review article on COVID-19 and Guillain-Barré syndrome.
Patnaik UJ
Front Biosci (Schol Ed); 2021 Jun; 13(1):97-104. PubMed ID: 34256532
[TBL] [Abstract][Full Text] [Related]
20. Incidence of Guillain-Barré Syndrome post COVID-19: a systematic review of case reports and case series.
Mahmoud H; Alhathla A; El-Fiky A; Alghamdi MS; Alwafi R; El-Sayed MS; Thabet AA; Alkhateeb AM; Elgendy SR; Hegazy R; Darweesh A
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2152-2164. PubMed ID: 36930515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
